山西医药杂志
山西醫藥雜誌
산서의약잡지
Shanxi Medical Journal
2015年
21期
2470-2472
,共3页
徐杲%华娴%华婷琰%陆雯
徐杲%華嫻%華婷琰%陸雯
서고%화한%화정염%륙문
幽门螺杆菌%慢性胃炎%标准三联疗法%益生菌
幽門螺桿菌%慢性胃炎%標準三聯療法%益生菌
유문라간균%만성위염%표준삼련요법%익생균
Helicobacter pylori%Chronic gastritis%Standard triple therapy%Probiotics
目的探讨标准三联疗法联合益生菌治疗幽门螺杆菌(Hp)相关慢性胃炎的疗效.方法将130例Hp阳性的慢性胃炎患者按照随机数字表分为三联组(65例)和联合组(65例).三联组给予标准三联疗法(阿莫西林+克拉霉素+雷贝拉唑,联合组给予标准三联疗法+益生菌,疗程均为2周.评估患者的临床症状改善情况,结束4周复查Hp并随访1年,比较2组Hp根除率、复发率及不良反应.结果治疗1周、2周后,2组临床症状评分均显著降低,联合组临床症状评分明显低于三联组(P<0.05);治疗2周后,联合组的总有效率为94%,高于其治疗1周时的77%,也显著高于三联组82%(P<0.05);联合组Hp根除率、1年复发率分别为86%、12%,三联组分别为71%、28%,差异均有统计学意义(P<0.05);联合组不良反应发生率分别为15%,显著低于三联组32%(P<0.05).结论标准三联疗法联合益生菌治疗Hp相关慢性胃炎,可明显提高Hp的根治率,减轻胃黏膜炎症程度,降低复发率及胃肠道的不良反应.
目的探討標準三聯療法聯閤益生菌治療幽門螺桿菌(Hp)相關慢性胃炎的療效.方法將130例Hp暘性的慢性胃炎患者按照隨機數字錶分為三聯組(65例)和聯閤組(65例).三聯組給予標準三聯療法(阿莫西林+剋拉黴素+雷貝拉唑,聯閤組給予標準三聯療法+益生菌,療程均為2週.評估患者的臨床癥狀改善情況,結束4週複查Hp併隨訪1年,比較2組Hp根除率、複髮率及不良反應.結果治療1週、2週後,2組臨床癥狀評分均顯著降低,聯閤組臨床癥狀評分明顯低于三聯組(P<0.05);治療2週後,聯閤組的總有效率為94%,高于其治療1週時的77%,也顯著高于三聯組82%(P<0.05);聯閤組Hp根除率、1年複髮率分彆為86%、12%,三聯組分彆為71%、28%,差異均有統計學意義(P<0.05);聯閤組不良反應髮生率分彆為15%,顯著低于三聯組32%(P<0.05).結論標準三聯療法聯閤益生菌治療Hp相關慢性胃炎,可明顯提高Hp的根治率,減輕胃黏膜炎癥程度,降低複髮率及胃腸道的不良反應.
목적탐토표준삼련요법연합익생균치료유문라간균(Hp)상관만성위염적료효.방법장130례Hp양성적만성위염환자안조수궤수자표분위삼련조(65례)화연합조(65례).삼련조급여표준삼련요법(아막서림+극랍매소+뢰패랍서,연합조급여표준삼련요법+익생균,료정균위2주.평고환자적림상증상개선정황,결속4주복사Hp병수방1년,비교2조Hp근제솔、복발솔급불량반응.결과치료1주、2주후,2조림상증상평분균현저강저,연합조림상증상평분명현저우삼련조(P<0.05);치료2주후,연합조적총유효솔위94%,고우기치료1주시적77%,야현저고우삼련조82%(P<0.05);연합조Hp근제솔、1년복발솔분별위86%、12%,삼련조분별위71%、28%,차이균유통계학의의(P<0.05);연합조불량반응발생솔분별위15%,현저저우삼련조32%(P<0.05).결론표준삼련요법연합익생균치료Hp상관만성위염,가명현제고Hp적근치솔,감경위점막염증정도,강저복발솔급위장도적불량반응.
Objective To explore clinical effectiveness of probiotics combined with standard triple therapy in helicobacter pylori(Hp) infection associated chronic gastritis .Methods A total of 130 chronic gastritis patients with Hp positive were randomly divided into two groups according to random number table .Triple group was treated with rabeprazole+clarithromycin+amoxicillin ,and combined group was given probiotics additionally .Af-ter 2 weeks of treatment ,the improvement of clinical symptoms were evaluated .Four weeks after the treatment , Hp infection was rechecked and followed up for 1 year to assess the Hp eradication rate ,recurrence rate and side effects during treatment .Results After treatment for 1 and 2 weeks ,the scores of clinical symptoms were all re-duced ,and the scores in combined group were significantly lower than those in triple group(P< 0.05) .After treatment for 2 weeks ,the total effective rate in combined group was 94% ,which was significantly higher than 77% of treatment for 1 weeks and 82% in triple group (P<0.05) .There was significant difference on Hp eradica-tion rate and 1-year recurrence rate between combined group and triple group (86% vs 71% ,12% vs 28% ) (P<0.05) .The rate of side effects in combined group and triple group was 15% and 32% ,it was statistically different between the two groups (P<0.05) .Conclusion Combined use of probiotics on the basis of standard triple therapy for treating chronic gastritis patients with Hp infection can obviously increase the Hp eradication rate ,improve gastric mucosal inflammation and reduce the recurrence rate and gastrointestinal side effects .